Expression of decorin in intestinal tissues of mice with inflammatory bowel disease and its correlation with autophagy

The aim of this study was to investigate the expression of decorin (DCN) in the intestinal tissues of mice with inflammatory bowel disease (IBD) and its correlation with autophagy. The IBD mouse model was created by intrarectal injection of trinitrobenzene sulfonic acid. The pathology of colon tissues of the mice was examined using hematoxylin and eosin staining. Expression of DCN and the proteins associated with autophagy was detected using immunohistochemistry. Normal human colon mucosal epithelial cells (NCM460 cells) were transfected with DCN expression plasmid and the expression of DCN and autophagy-associated proteins was detected by western blot analysis. Cell apoptosis was studied using an Annexin V apoptosis detection assay and intracellular autophagosomes were observed using electron microscopy. The IBD mouse model was successfully established. Thickening, edema and inflammatory cell infiltration of the intestinal wall were observed in the IBD mice. The expression of DCN as well as the autophagy-associated proteins beclin 1 and LC3B, was increased in the intestinal tissues of the IBD mice. Furthermore, in the NCM460 cells transfected with DCN, the expression of beclin 1 and LC3B was upregulated, while p62 expression was downregulated. Intracellular autophagosomes were increased and apoptosis was decreased in the cells with DCN overexpression. Inhibition of autophagy reversed the effects of DCN on apoptosis. Therefore, DCN is able to induce autophagy and protect intestinal cells during the occurrence and development of IBD.

[1]  S. Brennecke,et al.  Decorin expression is decreased in first trimester placental tissue from pregnancies with small for gestation age infants at birth. , 2016, Placenta.

[2]  M. Neurath,et al.  Immunopathogenesis of IBD: Batf as a Key Driver of Disease Activity , 2016, Digestive Diseases.

[3]  J. Fichna,et al.  Is insulin-like growth factor 1 (IGF-1) system an attractive target inflammatory bowel diseases? Benefits and limitation of potential therapy , 2016, Pharmacological reports : PR.

[4]  V. Annese,et al.  Impact of New Treatments on Hospitalisation, Surgery, Infection, and Mortality in IBD: a Focus Paper by the Epidemiology Committee of ECCO. , 2016, Journal of Crohn's & colitis.

[5]  B. Xia,et al.  Risk factors for initial surgery in patients with Crohn’s disease in Central China , 2015, Surgery Today.

[6]  B. Viollet,et al.  The PRKAA1/AMPKα1 pathway triggers autophagy during CSF1-induced human monocyte differentiation and is a potential target in CMML , 2015, Autophagy.

[7]  X. Chen,et al.  miR-19b downregulates intestinal SOCS3 to reduce intestinal inflammation in Crohn’s disease , 2015, Scientific Reports.

[8]  Lulu Chen,et al.  Depletion of Kupffer cells attenuates systemic insulin resistance, inflammation and improves liver autophagy in high-fat diet fed mice. , 2015, Endocrine journal.

[9]  V. Palumbo,et al.  Validation of a modified model of TNBS-induced colitis in rats. How to induce a chemical colitis in rats. , 2015, Acta bio-medica : Atenei Parmensis.

[10]  Ling-Feng Wang,et al.  Autophagy is deficient in nasal polyps: implications for the pathogenesis of the disease , 2015, International forum of allergy & rhinology.

[11]  H. Simon,et al.  Protective role of autophagy and autophagy-related protein 5 in early tumorigenesis , 2015, Journal of Molecular Medicine.

[12]  K. Uzawa,et al.  Decorin in human oral cancer: a promising predictive biomarker of S-1 neoadjuvant chemosensitivity. , 2015, Biochemical and biophysical research communications.

[13]  I. Lawrance,et al.  Mechanisms of initiation and progression of intestinal fibrosis in IBD , 2015, Scandinavian journal of gastroenterology.

[14]  S. Travis,et al.  Conventional drug therapy for inflammatory bowel disease , 2015, Scandinavian journal of gastroenterology.

[15]  S. Mehandru,et al.  Immune Cell Therapy in IBD , 2014, Digestive Diseases.

[16]  F. Aydın,et al.  Assessment of active mucosal inflammation in IBD patients in clinical remission. , 2014, Journal of gastrointestinal and liver diseases : JGLD.

[17]  T. Pizarro,et al.  Mechanisms and Models for Intestinal Fibrosis in IBD , 2014, Digestive Diseases.

[18]  J. Hegarty,et al.  An interleukin-4 polymorphism is associated with susceptibility to Clostridium difficile infection in patients with inflammatory bowel disease: results of a retrospective cohort study. , 2014, Surgery.

[19]  Z. Ahmed,et al.  Decorin treatment of spinal cord injury , 2014, Neural regeneration research.

[20]  R. Eliakim,et al.  Expression of IL-2, IL-17 and TNF-alpha in patients with Crohn's disease treated with anti-TNF antibodies. , 2014, Clinics and research in hepatology and gastroenterology.

[21]  Y. Kohgo,et al.  MicroRNA‐146b improves intestinal injury in mouse colitis by activating nuclear factor‐κB and improving epithelial barrier function , 2013, The journal of gene medicine.

[22]  Hiroki Wakabayashi,et al.  Decorin Suppresses Bone Metastasis in a Breast Cancer Cell Line , 2008, Oncology.

[23]  R. Iozzo,et al.  Decorin prevents metastatic spreading of breast cancer , 2005, Oncogene.

[24]  R. Iozzo,et al.  Absence of decorin adversely influences tubulointerstitial fibrosis of the obstructed kidney by enhanced apoptosis and increased inflammatory reaction. , 2002, The American journal of pathology.

[25]  J. Uitto,et al.  Transcriptional regulation of decorin gene expression. Induction by quiescence and repression by tumor necrosis factor-alpha , 1995, The Journal of Biological Chemistry.